Cross-sectional Evaluation of the Relationship Between Vitamin D Status and Supplement Use Across Levels of Kidney Function in Adults

Overview

Journal BMJ Open

Specialty General Medicine

Date 2019 Feb 25

PMID 30798303

Authors

Linda W Moore

Wadi N Suki

Keri E Lunsford

Omaima M Sabek

Richard J Knight

A Osama Gaber

Affiliations

Soon will be listed here.

Abstract

Objectives: The objective of this study was to assess vitamin D status of US non-pregnant adults using a standardised assay across 15 mL/min/1.73 m increments of kidney function, report the use of dietary supplements containing vitamin D and assess relationships between vitamin D and markers of bone resorption.

Design: This study is a cross-sectional evaluation.

Setting: The study is from the US National Health and Nutrition Evaluation Survey in 2001-2012.

Participants: The participants were non-institutionalised, non-pregnant adults, age ≥20 years.

Primary And Secondary Outcome Measures: The primary outcome measure was serum 25OHD evaluated using liquid chromatography-tandem mass spectroscopy traceable to international reference standards. Secondary outcome measures were use of dietary supplements containing vitamin D and the serum intact parathyroid hormone and bone-specific alkaline phosphatase in a subset of participants.

Results: The median 25OHD concentration in 27 543 US non-pregnant adults was 25.7 ng/mL (range, 2.2-150.0 ng/mL). Vitamin D supplements were used by 38.0%; mean (SE)=757 (43) international units/day. The range of 25OHD concentration across groups, stratified by kidney function, was 23.0-28.1 ng/mL. The lowest concentration of 25OHD observed was in people with higher kidney function (23.0 ng/mL for estimated glomerular filtration rate >105 mL/min/1.73 m). Only 24% of people not taking a dietary supplement had a 25OHD concentration >30 ng/mL. Serum intact parathyroid hormone inversely correlated with 25OHD within all kidney function groups. Bone-specific alkaline phosphatase was also negatively associated with 25OHD concentration.

Conclusions: These data indicate that 25OHD concentrations and supplement use may be suboptimal in a significant proportion of the population, across all kidney function levels. The response of bone resorption markers further suggests that 25OHD levels could be improved. Together, these data support a re-evaluation of the 25OHD concentration associated with health in adults.

References

Carrero J, Stenvinkel P . Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol. 2009; 4 Suppl 1:S49-55. DOI: 10.2215/CJN.02720409. View

Krause R, Stange R, Roth H, Kaase H, Michalsen A, Holick M . Partial Body UV Exposure in Chronic Kidney Disease and Extrarenal Vitamin D Metabolism. Anticancer Res. 2018; 38(2):1217-1219. DOI: 10.21873/anticanres.12342. View

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

Yetley E, Pfeiffer C, Schleicher R, Phinney K, Lacher D, Christakos S . NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr. 2010; 140(11):2030S-45S. PMC: 2955879. DOI: 10.3945/jn.110.121483. View

Powe C, Evans M, Wenger J, Zonderman A, Berg A, Nalls M . Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369(21):1991-2000. PMC: 4030388. DOI: 10.1056/NEJMoa1306357. View

Manson J, Brannon P, Rosen C, Taylor C . Vitamin D Deficiency - Is There Really a Pandemic?. N Engl J Med. 2016; 375(19):1817-1820. DOI: 10.1056/NEJMp1608005. View

Blum M, Dolnikowski G, Seyoum E, Harris S, Booth S, Peterson J . Vitamin D(3) in fat tissue. Endocrine. 2008; 33(1):90-4. PMC: 2839878. DOI: 10.1007/s12020-008-9051-4. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Dusso A, Tokumoto M . Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int. 2011; 79(7):715-29. DOI: 10.1038/ki.2010.543. View

10.

Dankers W, Colin E, van Hamburg J, Lubberts E . Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol. 2017; 7:697. PMC: 5247472. DOI: 10.3389/fimmu.2016.00697. View

11.

LaClair R, Hellman R, Karp S, Kraus M, Ofner S, Li Q . Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005; 45(6):1026-33. DOI: 10.1053/j.ajkd.2005.02.029. View

12.

Nielson C, Jones K, Bouillon R, Chun R, Jacobs J, Wang Y . Role of Assay Type in Determining Free 25-Hydroxyvitamin D Levels in Diverse Populations. N Engl J Med. 2016; 374(17):1695-6. PMC: 4870041. DOI: 10.1056/NEJMc1513502. View

13.

Andrassy K . Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. Kidney Int. 2013; 84(3):622-3. DOI: 10.1038/ki.2013.243. View

14.

Taal M, Thurston V, McIntyre N, Fluck R, McIntyre C . The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease. Kidney Int. 2014; 86(2):407-13. DOI: 10.1038/ki.2013.537. View

15.

Mirhosseini N, Vatanparast H, Mazidi M, Kimball S . The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab. 2017; 102(9):3097-3110. DOI: 10.1210/jc.2017-01024. View

16.

Isakova T, Gutierrez O, Patel N, Andress D, Wolf M, Levin A . Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr. 2010; 21(4):295-302. DOI: 10.1053/j.jrn.2010.07.002. View

17.

Park J, Ryu S, Han M, Choi S . The Association of Vitamin D With Estimated Glomerular Filtration Rate and Albuminuria: 5th Korean National Health and Nutritional Examination Survey 2011-2012. J Ren Nutr. 2016; 26(6):360-366. DOI: 10.1053/j.jrn.2016.07.003. View

18.

Drincic A, Armas L, Van Diest E, Heaney R . Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012; 20(7):1444-8. DOI: 10.1038/oby.2011.404. View

19.

Forman J, Scott J, Ng K, Drake B, Suarez E, Hayden D . Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013; 61(4):779-85. PMC: 3775458. DOI: 10.1161/HYPERTENSIONAHA.111.00659. View

20.

Pfeifer M, Begerow B, Minne H, Nachtigall D, Hansen C . Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001; 86(4):1633-7. DOI: 10.1210/jcem.86.4.7393. View